Screening for Swallowing Problems in Patients Following Prolonged Intubation: Validation of the Toronto Bedside Swallowing Screening Test (TOR-BSST©)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01411306|
Recruitment Status : Completed
First Posted : August 8, 2011
Last Update Posted : October 31, 2016
|Condition or disease||Intervention/treatment|
|Dysphagia||Other: Toronto Bedside Swallowing Screening Test (TOR-BSST©) Procedure: Videofluoroscopic Swallow Study|
|Study Type :||Observational|
|Actual Enrollment :||100 participants|
|Study Start Date :||May 2011|
|Actual Primary Completion Date :||November 2015|
|Med/Surg ICU Inpatients, Intubated ≥ 48 hours||
Other: Toronto Bedside Swallowing Screening Test (TOR-BSST©)
All enrolled patients will be screened for dysphagia by two blinded screeners using the TOR-BSST©.Procedure: Videofluoroscopic Swallow Study
All enrolled patients will undergo a videofluoroscopic assessment of swallowing within 24 hours of being screened with the TOR-BSST©.
- Validity of the TOR-BSST© [ Time Frame: 24 hours ]The validity of the TOR-BSST© will be measured using sensitivity, specificity, likelihood ratios, positive predictive value (PPV), and negative predictive value (NPV). Results of the videofluoroscopic assessment of swallowing will be used as the gold standard comparison.
- Inter-rater reliability of the TOR-BSST© [ Time Frame: 24 hours ]Inter-rater reliability will be calculated using the intraclass correlation coefficient (ICC).
- Estimation of the incidence of dysphagia in adult acute patients following prolonged intubation [ Time Frame: 24 hours ]
- Description of the impairment characteristics of dysphagia in adult acute patients following prolonged intubation [ Time Frame: 24 hours ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01411306
|University Health Network|
|Toronto, Ontario, Canada, M5G 2C4|
|Principal Investigator:||Rosemary Martino, PhD||University of Toronto / University Health Network|